SCHEMBL855757

SCHEMBL855757

CN(C)c1ccc(CNc2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA9 Q16790 1/20 0.59
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
GAA P10253 2/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
CYP1A2 P05177 3/20 0.58
CYP3A4 P08684 3/20 0.58
CYP2C19 P33261 2/20 0.58
CYP2C9 P11712 1/20 0.58
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
HTT P42858 2/20 0.53
NOS1 P29475 1/20 0.51
KDM1A O60341 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7345587 0.92 HTT (0.63) CA1CA2CA9NPC1RAB9A
SCHEMBL856237 0.90 CA1 (0.70) CA1CA2CA9NPC1RAB9A
SCHEMBL2065031 0.83 CYP1A2 (0.69) CA1CA2CA9MEN1KMT2A
SCHEMBL9657157 0.83 HTT (0.53) CA1CA2CA9NPC1RAB9A
SCHEMBL9658358 0.83 HTT (0.53) CA1CA2CA9NPC1RAB9A
SCHEMBL855759 0.83 ALDH1A1 (0.62) CA1CA2CA9NPC1RAB9A
SCHEMBL855663 0.83 ALDH1A1 (0.64) CA1CA2CA9NPC1RAB9A
SCHEMBL2990622 0.81 CA1 (0.65) CA1CA2CA9NPC1RAB9A
SCHEMBL855107 0.81 CA1 (0.60) CA1CA2CA9NPC1RAB9A
SCHEMBL10668237 0.81 ALDH1A1 (0.61) CA1CA2CA9NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006060654-A2 PESTICIDAL COMPOSITIONS AND METHODS DIVERGENCE, INC. (US) 2006-06-08 WO claimed
US-20050203067-A1 Pesticidal compositions and methods DIVERGENCE, INC. 2005-09-15 US claimed
CN-115745808-B Method for preparing secondary amine compound by catalyzing reduction of imine compound 延安大学 2024-04-30 CN disclosed
CN-115745808-A Method for preparing secondary amine compound by catalyzing reduction of imine compound 延安大学 2023-03-07 CN disclosed
EP-1318140-B9 NOVEL AMIDE DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2014-05-21 EP disclosed
CN-1474803-B Amide derivatives and their use for the preparation of medicaments MITSUBISHI TANABE PHARMA CORP 2012-11-21 CN disclosed
CN-1950750-B Pattern forming material, pattern forming apparatus, and pattern forming method ASAHI KASEI E MATERIALS CORP 2012-10-24 CN disclosed
CN-101052918-B Photosensitive composition, pattern forming material, photosensitive laminate, pattern forming apparatus, and pattern forming method ASAHI KASEI E MATERIALS CORP 2012-09-26 CN disclosed
US-8198454-B2 Amide derivatives and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-06-12 US disclosed
EP-1308438-B9 3-SUBSTITUTED UREA DERIVATIVES AND MEDICINAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2012-03-28 EP disclosed
CN-101103310-B Material for pattern formation, apparatus for pattern formation, and method for pattern formation FUJI FILM CORP 2012-03-14 CN disclosed
CN-1641481-A Light-sensitive transfer sheet, light-sensitive layers, method for forming image pattern and method for distribution pattern FUJI PHOTO FILM CO LTD (JP) 2005-07-20 CN disclosed
CN-1580953-A Light-sensitive transfer sheet, light-sensitive layers, picture pattern forming method and layout pattern forming method FUJI PHOTO FILM CO LTD (JP) 2005-02-16 CN disclosed
CN-1573545-A Light-sensitive sheet, light-sensitive layers, image pattern forming method, and wiring pattern forming method FUJI PHOTO FILM CO LTD (JP) 2005-02-02 CN disclosed
US-20040138223-A1 Novel amide derivatives and medicinal use thereof ugs MITSUBISHI TANABE PHARMA CORPORATION (JP) 2004-07-15 US disclosed
CN-1474803-A Novel amide derivative and medical use thereof ������ҩ��ʽ���� 2004-02-11 CN disclosed
CN-1466569-A Novel 3-substituted urea derivatives and pharmaceutical use thereof ������ҩ��ʽ���� 2004-01-07 CN disclosed
US-20030207939-A1 Novel 3-substituted urea derivatives and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2003-11-06 US disclosed
EP-1318140-A1 NOVEL AMIDE DERIVATIVES AND MEDICINAL USE THEREOF UGS Mitsubishi Pharma Corporation (JP) 2003-06-11 EP disclosed
EP-1308438-A1 3-SUBSTITUTED UREA DERIVATIVES AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-05-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207939-A1 Novel 3-substituted urea derivatives and medicinal use thereof C5AR1, C5AR2, C3AR1 CA1 2217/4885CA2 4353/4885CA9 4324/4885
US-20050203067-A1 Pesticidal compositions and methods ACHE, DDT, PTMS CA1 498/4885CA2 701/4885CA9 1371/4885
US-20040138223-A1 Novel amide derivatives and medicinal use thereof ugs C5AR1, C5AR2, C1S CA1 1620/4885CA2 3991/4885CA9 3969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.